Breast Lift in Manaus BR
Breast Lift in Manaus section, includes general infrmation about Breast Lift Procedure, Breast Lift Manaus Local News, Breast Lift Manaus Surgeon Locator and other Breast Lift related material.
Breast Lift Procedure
A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).
Other Breast Lift Procedures
All Breast Procedures
Breast Lift manaus (current)
manaus Breast Reduction
manaus Breast Implants
manaus Implant Removal
manaus Armpit Incision
More Manaus info...
Manaus By bus
Due to road conditions, there is very little (if any) long-distance bus service originating from major cities in Brazil. There are daily buses to Boa Vista in the north and to destinations in Venezuela. The bus from Caracas in Venezula takes about 36 hours, but it is air-conditioned, has comfortable reclining seats and a toilet.
-
Manaus Budget
Lots of cheap hotels and pens?es can be found in the area around Av. Joaquim Nabuco.
Hotel Brasil Av. Get?lio Vargas, 657 - Centro Manaus, Phone: 55 92 xx 30824732, Email: E-Mail privileged localization in the center of the city, next to the main tourist points as the Theater Amazon, Palace Rio Negro, Municipal Market, Porto and Zona Franca of Manaus . eco turismo amazonas trips
Hotel Rio Branco, Rua dos Andradas 484, 233-4019. A real backpacker dive. Rooms are tiny and in some cases without windows.
Hotel Alvorada:Rua Quintinho Bocai?va n? 583, Manaus Center -
Plastic Surgery News...
- Bulging waistlines may be to blame for a rise in strokes among middle-aged women, researchers report.
- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced that it has advanced CR011-vcMMAE, an antibody-drug conjugate (ADC), into Phase II for the treatment of patients with unresectable Stage III and Stage IV melanoma.